ProShare Advisors’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Sell |
13,171
-851
| -6% | -$7.5K | ﹤0.01% | 1852 |
|
|
2025
Q1 | $105K | Sell |
14,022
-3,403
| -20% | -$25.5K | ﹤0.01% | 1825 |
|
|
2024
Q4 | $145K | Buy |
+17,425
| New | +$145K | ﹤0.01% | 1977 |
|
|
2024
Q3 | – | Sell |
-4,871
| Closed | -$23.9K | – | 2125 |
|
|
2024
Q2 | $23.9K | Buy |
+4,871
| New | +$23.9K | ﹤0.01% | 1802 |
|
|
2022
Q1 | – | Sell |
-11,452
| Closed | -$100K | – | 2312 |
|
|
2021
Q4 | $100K | Buy |
+11,452
| New | +$100K | ﹤0.01% | 2207 |
|
|
2016
Q3 | – | Sell |
-681
| Closed | -$43K | – | 1521 |
|
|
2016
Q2 | $43K | Buy |
681
+16
| +2% | +$1.01K | ﹤0.01% | 1558 |
|
|
2016
Q1 | $154K | Sell |
665
-61
| -8% | -$14.1K | ﹤0.01% | 1465 |
|
|
2015
Q4 | $231K | Buy |
+726
| New | +$231K | ﹤0.01% | 1456 |
|